Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma-Reference-Cited by-同舟云学术

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

Published:2023-07-17 Issue:26 Volume:14 Page:2715-2731
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Wang Qian¹,Xu Chunwei²³⁴^ORCID,Wang Wenxian³^ORCID,Zhang Yongchang⁵^ORCID,Li Ziming⁶,Song Zhengbo³^ORCID,Wang Jiandong⁷,Yu Jinpu⁸,Liu Jingjing⁹,Zhang Shirong¹⁰^ORCID,Cai Xiuyu¹¹,Li Wen¹²,Zhan Ping⁴^ORCID,Liu Hongbing⁴^ORCID,Lv Tangfeng⁴^ORCID,Miao Liyun¹³^ORCID,Min Lingfeng¹⁴,Li Jiancheng¹⁵,Liu Baogang¹⁶,Yuan Jingping¹⁷,Jiang Zhansheng¹⁸^ORCID,Lin Gen¹⁹^ORCID,Chen Xiaohui²⁰,Pu Xingxiang²¹,Rao Chuangzhou²²,Lv Dongqing²³,Yu Zongyang²⁴,Li Xiaoyan²⁵,Tang Chuanhao²⁶,Zhou Chengzhi²⁷^ORCID,Zhang Junping²⁸,Guo Hui²⁹,Chu Qian³⁰,Meng Rui³¹,Liu Xuewen³²,Wu Jingxun³³,Hu Xiao³⁴,Zhou Jin³⁵,Zhu Zhengfei³⁶^ORCID,Chen Xiaofeng³⁷,Pan Weiwei³⁸,Pang Fei³⁹,Zhang Wenpan³⁹,Jian Qijie³⁹,Wang Kai³⁹,Wang Liping⁴⁰,Zhu Youcai⁴¹,Yang Guocai⁴²,Lin Xinqing²⁷^ORCID,Cai Jing⁴³^ORCID,Feng Huijing²⁸,Wang Lin⁴⁴,Du Yingying⁴⁵^ORCID,Yao Wang⁴⁶,Shi Xuefei⁴⁷,Niu Xiaomin⁶,Yuan Dongmei⁴,Yao Yanwen⁴,Huang Jianhui⁴⁸,Wang Xiaomin³⁸,Zhang Yinbin⁴⁹,Sun Pingli⁵⁰,Wang Hong⁵¹,Ye Mingxiang⁴,Wang Dong⁴,Wang Zhaofeng⁴,Hao Yue³^ORCID,Wang Zhen⁵²,Wan Bing⁵³,Lv Donglai⁵⁴^ORCID,Yu Jianwei⁵⁵,Kang Jin⁵⁶,Zhang Jiatao⁵⁶,Zhang Chao⁵⁶,Wu Lixin⁴¹,Shi Lin⁵⁷,Ye Leiguang¹⁶,Wang Gaoming⁵⁸,Wang Yina⁵⁹,Gao Feng⁶⁰,Huang Jianfei⁶¹,Wang Guifang⁶²,Wei Jianguo⁶³,Huang Long⁴³^ORCID,Li Bihui⁶⁴,Zhang Zhang⁶⁵,Li Zhongwu⁶⁶,Liu Yueping⁶⁷,Li Yuan⁶⁸,Liu Zhefeng⁵¹,Yang Nong⁵,Wu Lin²¹,Wang Qiming⁶⁹,Huang Wenbin⁷⁰,Hong Zhuan⁷¹,Wang Guansong⁷²,Qu Fengli²,Fang Meiyu³,Fang Yong⁷³,Zhu Xixu⁵²,Du Kaiqi⁴¹,Ji Jiansong⁷⁴,Shen Yi⁷⁵^ORCID,Chen Jing³¹,Zhang Yiping³,Ma Shenglin⁷⁶,Lu Yuanzhi⁷⁷^ORCID,Song Yong⁴^ORCID,Liu Anwen⁴³,Zhong Wenzhao⁵⁶^ORCID,Fang Wenfeng⁷⁸

Affiliation:

1. Department of Respiratory Medicine Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine Nanjing China

2. Institute of Cancer and Basic Medicine (ICBM) Chinese Academy of Sciences Hangzhou China

3. Department of Chemotherapy Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital) Hangzhou China

4. Department of Respiratory Medicine Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing China

5. Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

6. Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

7. Department of Pathology Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing China

8. Department of Cancer Molecular Diagnostics Core Tianjin Medical University Cancer Institute and Hospital Tianjin China

9. Department of Thoracic Cancer Jilin Cancer Hospital Changchun China

10. Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center Zhejiang University School of Medicine Hangzhou China

11. Department of VIP Inpatient, Sun Yet‐Sen University Cancer Center, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou China

12. Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center Zhejiang University Hangzhou China

13. Department of Respiratory Medicine, Affiliated Drum Tower Hospital Medical School of Nanjing University Nanjing China

14. Department of Respiratory Medicine Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province Yangzhou China

15. Department of Radiation Oncology Fujian Medical University Cancer Hospital & Fujian Cancer Hospital Fuzhou China

16. Department of Oncology Harbin Medical University Cancer Hospital Harbin China

17. Department of Pathology Renmin Hospital of Wuhan University Wuhan China

18. Department of Integrative Oncology Tianjin Medical University Cancer Institute and Hospital Tianjin China

19. Department of Medical Oncology Fujian Medical University Cancer Hospital & Fujian Cancer Hospital Fuzhou China

20. Department of Thoracic Surgery Fujian Medical University Cancer Hospital & Fujian Cancer Hospital Fuzhou China

21. Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

22. Department of Radiotherapy and Chemotherapy, Hwamei Hospital University of Chinese Academy of Sciences Ningbo China

23. Department of Pulmonary Medicine Taizhou Hospital of Wenzhou Medical University Taizhou China

24. Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital) Fujian Medical University Fuzhou China

25. Department of Oncology, Beijing Tiantan Hospital Capital Medical University Beijing China

26. Department of Medical Oncology Peking University International Hospital Beijing China

27. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University) Guangzhou China

28. Department of Thoracic Oncology Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital Taiyuan China

29. Department of Medical Oncology The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

30. Department of Oncology, Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China

31. Cancer Center, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

32. Department of Oncology, the Third Xiangya Hospital Central South University Changsha China

33. Department of Medical Oncology, the First Affiliated Hospital of Medicine Xiamen University Xiamen China

34. Zhejiang Key Laboratory of Radiation Oncology Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou China

35. Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology Chengdu China

36. Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China

37. Department of Oncology Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital Nanjing China

38. Department of Cell Biology, College of Medicine Jiaxing University Jiaxing China

39. Department of Medical Shanghai OrigiMed Co, Ltd Shanghai China

40. Department of Oncology Baotou Cancer Hospital Baotou China

41. Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital The Third Affiliated Hospital of Jiaxing University Jiaxing China

42. Department of Thoracic Surgery, Zhoushan Hospital Wenzhou Medical University Zhoushan China

43. Department of Oncology Second Affiliated Hospital of Nanchang University Nanchang China

44. Department of Pathology Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital Taiyuan China

45. Department of Oncology The First Affiliated Hospital of Anhui Medical University Hefei China

46. Department of Interventional Oncology The First Affiliated Hospital, Sun Yat‐sen University Guangzhou China

47. Department of Respiratory Medicine, Huzhou Hospital Zhejiang University School of Medicine Huzhou China

48. Department of Oncology Lishui Municipal Central Hospital Lishui China

49. Department of Oncology the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University Xi'an China

50. Department of Pathology The Second Hospital of Jilin University Changchun China

51. Senior Department of Oncology The 5th Medical Center of PLA General Hospital Beijing China

52. Department of Radiation Oncology Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing China

53. Department of Respiratory Medicine The Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China

54. Department of Clinical Oncology The 901 Hospital of Joint Logistics Support Force of People Liberation Army Hefei China

55. Department of Respiratory Medicine Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi Province Hospital of Chinese Medicine Nanchang China

56. Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine Guangzhou China

57. Department of Respiratory Medicine Zhongshan Hospital, Fudan University Shanghai China

58. Department of Thoracic Surgery, Xuzhou Central Hospital Xuzhou Clinical School of Xuzhou Medical University Xuzhou China

59. Department of Oncology, The First Affiliated Hospital, College of Medicine Zhejiang University Hangzhou China

60. Department of Thoracic Surgery The Fourth Hospital of Hebei Medical University Shijiazhuang China

61. Department of Clinical Biobank Affiliated Hospital of Nantong University Nantong China

62. Department of Respiratory Medicine Huashan Hospital, Fudan University Shanghai China

63. Department of Pathology Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine) Shaoxing China

64. Department of Oncology The Second Affiliated Hospital of Guilin Medical University Guilin China

65. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy Jinan University Guangzhou China

66. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology Peking University Cancer Hospital & Institute Beijing China

67. Department of Pathology The Fourth Hospital of Hebei Medical University Shijiazhuang China

68. Department of Pathology Fudan University Shanghai Cancer Center Shanghai China

69. Department of Internal Medicine The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou China

70. Department of Pathology the First Affiliated Hospital of Henan University of Science and Technology Luoyang China

71. Department of Medical Oncology, Jiangsu Cancer Hospital Nanjing Medical University Affiliated Cancer Hospital Nanjing China

72. Institute of Respiratory Diseases, Xinjian Hospital Third Military Medical University Chongqing China

73. Department of Medical Oncology, Sir Run Run Shaw Hospital Zhejiang University Hangzhou China

74. Department of Radiology Lishui Municipal Central Hospital Lishui China

75. Department of Thoracic Surgery, Affiliated Jinling Hospital Medical School of Nanjing University Nanjing China

76. Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center Zhejiang University School of Medicine Hangzhou China

77. Department of Clinical Pathology The First Affiliated Hospital of Jinan University Guangzhou China

78. Department of Medical Oncology, Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou China

Abstract

AbstractMalignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high‐risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow‐up.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.15022

Reference120 articles.

1. Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent

2. Malignant Mesothelioma of the Tunica Vaginalis Testis: Diagnostic Studies and Differential Diagnosis

3. Chinese guideline for clinical diagnosis and treatment of malignant pleural mesotheliom (2021 edition);Multidisciplinary Committee of Oncology, Chinese Physicians Association;Chin J Oncol,2021

4. Consensus on diagnosis and treatment of malignant pleural mesothelioma (MPM) (2022, Hangzhou);Mao W;Chin Cancer,2022

5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Mesothelioma: Pleural. Version 1. 2023‐December 15 2022.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated DNA methylation analysis of peripheral blood from asbestos exposed populations and patients with malignant mesothelioma reveals novel methylation driver genes of diagnostic and prognostic relevance;Environmental Pollution;2024-12

2. Ki67 Tumor Expression Predicts Treatment Benefit Achieved by Macroscopic Radical Lung-Preserving Surgery in Pleural Mesothelioma—A Retrospective Multicenter Analysis;Cancers;2024-05-10

3. Association Study of Pleural Mesothelioma and Oncogenic Simian Virus 40 in the Crocidolite-Contaminated Area of Dayao County, Yunnan Province, Southwest China;Genetic Testing and Molecular Biomarkers;2024-05-01